Popular on EntSun
- Systemores Launches Fork: Web-Native Interactive Video Engine Debuts With Thriller 'The Hollow' - 645
- SecureMaine 2026 is Here -- Thursday October 8th! - 512
- Russ Lorenson Announces "What I Want For Christmas (20th Anniversary Edition)" - 485
- HSS Medical Supply Celebrates One-Year Anniversary of Its Top Performing Sales Team - 473
- Wordeee Publishes The Designer's Path by Felita Harris - 468
- Captiva Cruises offers sunset voyage to Oct. 24 Swashbuckler's Ball on North Captiva - 448
- Tulsa Air & Space Museum Launches "Give $16 for the F-16" Challenge to Bring Thunderbird Home for Veterans Day - 438
- Claude Zdanow named Managing Director in Miami, Florida - 423
- Geospatial Innovation Comes to Sacramento: FOSS4G NA 2026 - 416
- Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1 - 408
Similar on EntSun
- Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
- Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
- Expanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC)
- Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Win Gold in Raleigh's Best Awards for Second Consecutive Year
- Mr Hospital Bed Cites Hill Rom Hospital Bed Models Best Value Home Care Hospital Beds 2026
- Hospital Direct Medical Equipment Company Seeing Growth in Used Refurbished Medical Equipment Sales
- Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
- Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Acuvance Survey Finds ERP Integration Remains a Key Challenge as Healthcare Organizations Prepare for AI
- HSS Medical Supply Celebrates One-Year Anniversary of Its Top Performing Sales Team
Voltas Completes SAM.gov Registration, Opening In-House Medical Device Work to Federal Buyers
EntSun News/11106715
Voltas of Cottage Grove, Minnesota, has an active SAM.gov registration (CAGE code 26GX5) as of October 27, 2026. Federal agencies and primes can now work with Voltas on medical device development, manufacturing and EtO sterilization in one facility.
COTTAGE GROVE, Minn. - EntSun -- COTTAGE GROVE, Minn. Voltas has completed its registration in the federal System for Award Management (SAM.gov). The registration became active on October 27, 2026, and Voltas holds CAGE code 26GX5. Federal agencies, military research groups and prime contractors can now contract directly with Voltas for medical device development and manufacturing.
Voltas keeps engineering, regulatory work, manufacturing and sterilization in one facility at 8200 97th Street, Cottage Grove, MN 55016. A federal program can bring a patented idea, a research prototype or a napkin sketch, and work with one team through production.
The Voltas team handles R&D, weekly prototyping, mold flow analysis, die mold tooling, injection molding, balloon development, hydrophilic and hydrophobic coatings, cleanroom assembly, packaging and labeling, and distribution. Voltas has on-site two-pallet EtO sterilization capacity and runs sterilization validation in house. The facility is ISO 13485 compliant. The regulatory team supports Pre-Sub, 513(g) and 510(k) work.
More on EntSun News
Government research programs often fund a device through early prototypes, then need a partner to take it to a build that can pass FDA review and scale. Voltas does both under one roof, so a program does not have to hand the design to a second company for tooling, assembly or sterilization.
Voltas has worked on 128 medical device projects and has 15 current clients. One project is sold in 10 countries.
Contracting officers and prime contractors can find Voltas on SAM.gov under CAGE code 26GX5, or reach the team at https://www.voltas.io.
About Voltas
Voltas is a medical device development and manufacturing company in Cottage Grove, Minnesota. Development Manufacturing. Everything. In House. Website: https://www.voltas.io. Phone: (651) 677-0675.
Media contact
Jason Scherer, CEO
jason.scherer@voltas.io
(651) 677-0675
https://www.voltas.io
Voltas keeps engineering, regulatory work, manufacturing and sterilization in one facility at 8200 97th Street, Cottage Grove, MN 55016. A federal program can bring a patented idea, a research prototype or a napkin sketch, and work with one team through production.
The Voltas team handles R&D, weekly prototyping, mold flow analysis, die mold tooling, injection molding, balloon development, hydrophilic and hydrophobic coatings, cleanroom assembly, packaging and labeling, and distribution. Voltas has on-site two-pallet EtO sterilization capacity and runs sterilization validation in house. The facility is ISO 13485 compliant. The regulatory team supports Pre-Sub, 513(g) and 510(k) work.
More on EntSun News
- RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase
- BOHO Design Rentals Gives Colorado's Cocktail Hour a Design-Forward Standard
- BOHO Design Rentals Anchors the Colorado Lounge With an Updated Coffee Table Page
- How Chlorinated Latex Is Quietly Revolutionizing Editorial Fashion & Red-Carpet Styling
- Heritage at Manalapan Announces New 3.875% First-Year Mortgage Rate Buydown (7.11 APR)
Government research programs often fund a device through early prototypes, then need a partner to take it to a build that can pass FDA review and scale. Voltas does both under one roof, so a program does not have to hand the design to a second company for tooling, assembly or sterilization.
Voltas has worked on 128 medical device projects and has 15 current clients. One project is sold in 10 countries.
Contracting officers and prime contractors can find Voltas on SAM.gov under CAGE code 26GX5, or reach the team at https://www.voltas.io.
About Voltas
Voltas is a medical device development and manufacturing company in Cottage Grove, Minnesota. Development Manufacturing. Everything. In House. Website: https://www.voltas.io. Phone: (651) 677-0675.
Media contact
Jason Scherer, CEO
jason.scherer@voltas.io
(651) 677-0675
https://www.voltas.io
Source: Voltas
0 Comments
Latest on EntSun News
- Not Every Story Is Ready to Be Told. That Doesn't Mean It Should Be Forgotten
- Immerse Yourself in the Historic Tochigi Autumn Festival, Celebrated Every Two Years Since 1874
- Western Canadian Host James Cousineau Finishes 11th In Global "Top Host" Competition
- Richmond Family Launches Birthday Battle Box: Nerf Party in a Crate, Shipped Free Across East Coast
- Former Texas Longhorn Launches Innrcirql, Creator Platform Where Fans Open Packs Instead of Paying
- Asheville Artist KayeDinero Turns the Blue Ridge Into a Horror Movie With "Halloween"
- Resident Inspect Expands Virtual Property Inspections With AppFolio and Rentvine Integrations
- Unlocking the Next Phase of Growth with New AI Innovations; Targeting 2027 as Breakeven; Revenue Momentum Accelerates: ZenaTech (N A S D A Q: ZENA)
- AeroNet Deploys netElastic vBNG and CGNAT with Tarana Wireless to Deliver Scalable, Fiber-Class Broadband Across Puerto Rico
- New Atlas Maps the 38 States Behind Every Conversation
- Atlanta Company Launches Free, Ad-Free, Nonpartisan Voter Planning App for All 50 States Ahead of the Nov. 3 Election
- Pastor Carlton L. Aiken Sr. Celebrates 55 Years with "Sermonic Selections"
- J. Wes Seeks Jazz Musicians, Vocalists and Bands for Philadelphia Live Music Event
- NECP Promotes Chertova to Senior Business Analyst
- Security Industry Veteran Anthony Rumore Launches AegisLead to Help Security Companies Find Business and Manage Growth
- Actor Ray Buffer Attends High-Profile "RUSH" Red Carpet Screening in Los Angeles
- Charlie Shaw and Patrick Carragher win SEO Agency of the Year 2026
- Canadian Woman Plants 1,667 Love Stories in a Field of Peonies That Could Bloom for 100 Years
- Is Podcasting The Death Of Radio? Radio Veterans Leave The "dial" In Favor Of Launching New Podcasts
- New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)